A kind of anti-enzymolysis antimicrobial peptide ii4ii and its preparation method and application

An antibacterial peptide and anti-enzymolysis technology, which is applied in the direction of antibacterial drugs, chemical instruments and methods, and medical preparations containing active ingredients, can solve the problems of reducing and losing biological activity, and achieve simple technical routes and improve antibacterial Enzyme hydrolysis ability, high application value effect

Active Publication Date: 2021-12-14
NORTHEAST AGRICULTURAL UNIVERSITY
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0004] Based on the above deficiencies, the object of the present invention is to provide an anti-enzymolysis antimicrobial peptide II4II and its preparation method and application, which solves the problem that it is easily degraded by protease to reduce or even lose its biological activity.

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • A kind of anti-enzymolysis antimicrobial peptide ii4ii and its preparation method and application
  • A kind of anti-enzymolysis antimicrobial peptide ii4ii and its preparation method and application
  • A kind of anti-enzymolysis antimicrobial peptide ii4ii and its preparation method and application

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0016] Design of Antimicrobial Peptides Against Enzyme

[0017] (1) Arg with high cationicity is selected as the cationic amino acid to provide the necessary net positive charge. In order to avoid the cleavage of Arg by trypsin, Cys and Lys were placed on the N-terminal side and C-terminal side of Arg, respectively, to block the cleavage of Arg by trypsin. At the same time, Pro was placed on the C-terminal side of Lys to block the cleavage of Lys by trypsin.

[0018] (2) In order to avoid cleavage by chymotrypsin and pepsin, Ile with a longer aliphatic side chain was selected as the hydrophobic amino acid and placed on the C-terminal side of Pro and the N-terminal side of Cys to provide the necessary hydrophobicity.

[0019] (3) Place two Ile respectively at the N-terminus and C-terminus of the sequence unit to enhance the hydrophobicity to further improve the activity.

[0020] The anti-enzymolytic antimicrobial peptide template is thus designed as: XX(XCRKPX)nXX-NH 2 , wh...

Embodiment 2

[0027] Synthesis of Antimicrobial Peptides by Solid Phase Chemical Synthesis

[0028] 1. The synthesis of antimicrobial peptides is carried out one by one from the C-terminal to the N-terminal by a peptide synthesizer. First, Fmoc-X (X is the first amino acid at the C-terminal of each antimicrobial peptide) is inserted into Wang resin, and then the Fmoc group is removed to obtain X-Wang resin; then Fmoc-Y-Trt-OH (9 -Fmoxy-trimethyl-Y, Y is the second amino acid at the C-terminus of each antimicrobial peptide); according to this procedure, it is synthesized from the C-terminus to the N-terminus until the synthesis is completed, and the side of the Fmoc group is removed chain protection resin;

[0029] 2. Add a cleavage reagent to the peptide resin obtained above, react at 20°C for 2 hours in the dark, filter; precipitate TFA (trifluoroacetic acid) and wash, then mix the washing liquid with the above filtrate, concentrate with a rotary evaporator, and then add About 10 times t...

Embodiment 3

[0033] Determination of Biological Activity of Antimicrobial Peptides

[0034] 1. Determination of antibacterial activity: The minimum inhibitory concentration (MIC) of the peptide was determined by the standard micro-broth dilution method. Dilute bacteria in log phase to 10 5 CFU / ml. Add 50 μl of different concentrations of peptides (the final concentration of peptides is 1-128 μM) and an equal volume of bacterial suspension to each well of a 96-well plate, and set up negative controls (medium only) and positive controls (bacteria and medium) at the same time , and then place the 96-well plate in a constant temperature incubator at 37°C for 18-20 hours. Using a microplate reader at 492nm (OD 492 ) to determine the minimum inhibitory concentration. Three independent replicates were performed, with two parallels for each replicate. The results are shown in Table 2.

[0035] Bacteriostatic activity (μM) of table 2 antimicrobial peptides

[0036]

[0037]

[0038] As...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

PUM

No PUM Login to view more

Abstract

The invention belongs to the field of biotechnology and provides an anti-enzymolysis antimicrobial peptide II4II and a preparation method and application thereof. The amino acid sequence of the antimicrobial peptide II4II is shown in SEQ ID No.1. Preparation method: Based on the specific cleavage sites of trypsin, chymotrypsin and pepsin and the basic characteristics of antimicrobial peptides, the amino acids in the sequence were rationally arranged, and Ile was selected as the hydrophobic amino acid to obtain antimicrobial peptides II4II. The application of the antimicrobial peptide II4II in the preparation of medicines for treating gastrointestinal infection caused by Gram-negative bacteria or / and Gram-positive bacteria. The antimicrobial peptide II4II of the present invention has strong inhibitory effect on various bacteria, and the hemolytic activity is low, the therapeutic index reaches 80.63, and has strong anti-enzymolysis ability, after trypsin or chymotrypsin or pepsin treatment, inhibition Bacterial activity remains unchanged, and has the potential to become a substitute for antibiotics.

Description

technical field [0001] The invention belongs to the field of biotechnology, and in particular relates to an anti-enzymolysis antimicrobial peptide II4II, a preparation method and application thereof. Background technique [0002] In the past 90 years, antibiotics have been widely used in medicine, food, animal husbandry and other industries. However, the abuse of antibiotics has accelerated the development of drug resistance, posing a great threat to global public health. Therefore, finding alternatives to antibiotics has become a top priority. Antimicrobial peptides (AMPs) widely exist in organisms in nature, have antibacterial, antifungal, anti-inflammatory and other biological activities, and are an important part of the host immune system. The unique non-specific membrane destruction mechanism of AMPs makes it difficult for bacteria to develop drug resistance, therefore, AMPs are considered to be the most promising alternatives to antibiotics. [0003] However, the cl...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to view more

Application Information

Patent Timeline
no application Login to view more
Patent Type & Authority Patents(China)
IPC IPC(8): C07K14/00A61K38/16A61P31/04
CPCC07K14/00A61P31/04A61K38/00
Inventor 单安山朱永杰邵长轩
Owner NORTHEAST AGRICULTURAL UNIVERSITY
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Try Eureka
PatSnap group products

Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic.

© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap